Steroids Market Report 2025 (Global Edition)

Global Steroids Market Report 2025 Market Size Split by Type (Corticosteroids, Hormones Steroids), by Form (Powder, Granule, Liquid), by Modes of Administration (Skin Patches, Inhalers, Oral, Injectio...

Steroids Market Report Description

We have various report editions of Steroids Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Steroids Market

The steroids market features intense competition among key players such as Pfizer, Merck, Novartis, and Sanofi, who dominate with extensive product portfolios and global market presence. Strategic initiatives such as mergers and acquisitions, product launches, and collaborations are common, driven by the pursuit of market share and innovation leadership.

Top Companies Market Share in Steroids Industry: (In no particular order of Rank)

• Cipla GSK
• Mission Pharmacia Company
• AstraZeneca
• Steroid
• Johnson and Johnson
• Hubei Gedian Humanwell Pharmaceutical Co. Ltd.
• Merck and Co. Inc.
• Hovione
• Halcyon Labs Pvt. Ltd.
• Novartis
• Pfizer
• Avik Pharma
• ASG Biochem Private Limited
• Switzer Life Science Pvt. Ltd.
• Sumit laboratories
• AstraZeneca
• STEROID S.p.A.
• Symbiotic
• Sanofi
• Anuh Pharma Limited
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

North America dominated the Market in 2024 and accounted for around 40% of the global revenue.

According to Cognitive Market Research, North America dominated the Market in 2024 and accounted for around 40% of the global revenue. The region boasts advanced healthcare infrastructure, a strong pharmaceutical industry, and high healthcare expenditure, fostering the adoption of steroid-based therapeutics. Moreover, increasing awareness about the benefits of corticosteroids in managing inflammatory conditions and the growing emphasis on sports and fitness contribute to market expansion. Regulatory frameworks ensure the safe use of steroids while addressing concerns related to misuse and abuse. However, challenges such as pricing pressures, generic competition, and stringent regulatory requirements persist. Overall, North America remains a key region for stakeholders in the steroids market, with continued investments in research and development and strategic collaborations driving innovation and market growth.

The European region is witnessing an increase in the sales of reagents. The region boasts a significant prevalence of autoimmune diseases, respiratory disorders, and dermatological conditions, driving the demand for corticosteroids. Furthermore, an aging population contributes to the rising incidence of hormone deficiencies, necessitating the use of anabolic steroids for therapeutic purposes. Regulatory frameworks in Europe ensure stringent oversight of steroid usage, emphasizing safety and efficacy—Additionally, advancements in healthcare infrastructure and increasing healthcare expenditure support market expansion. However, concerns regarding steroid misuse in sports and bodybuilding persist, prompting regulatory interventions. 

The current report Scope analyzes Steroids Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Steroids

According to Cognitive Market Research, the global Steroids market size was estimated at USD 3451.2 Million, out of which North America held the major Market of more than 40% of the global revenue with a market size of USD 1380.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.3% from 2024 to 2031. In North America, the steroids market is driven by factors such as the increasing prevalence of autoimmune diseases, rising demand for corticosteroids in the treatment of respiratory disorders like asthma and COPD, growing adoption of biologics and biosimilars, advancements in drug delivery technologies, expanding applications in oncology for managing side effects of chemotherapy, and rising geriatric population. Additionally, robust healthcare infrastructure, favorable reimbursement policies, and ongoing research and development activities contribute to market growth in the Region.

Europe Steroids

According to Cognitive Market Research, with a market value of USD 3451.2 million in 2024, it is projected to expand at a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031. Europe accounted for a share of over 30% of the global market size of USD 1035.36 million. Europe, the steroid market is driven by factors such as the increasing prevalence of chronic diseases like asthma and autoimmune disorders, the rising geriatric population, advancements in healthcare infrastructure, and growing awareness about the benefits of steroid therapy. Additionally, regulatory initiatives promoting the development and commercialization of innovative steroid formulations further propel market growth. These drivers foster a conducive environment for market expansion, shaping the Landscape of steroid usage and distribution across the European Region.

Asia Pacific Steroids

According to Cognitive Market Research, the global Steroids market size was estimated at USD 3451.2 Million, out of which Asia Pacific held the Market of around 23% of the global revenue with a market size of USD 793.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.1% from 2024 to 2031. In the Asia-Pacific region, the steroid market is driven by factors such as the increasing prevalence of chronic diseases, the rising geriatric population, the expanding healthcare infrastructure, and growing awareness about the benefits of steroid therapy. Additionally, the Region's evolving pharmaceutical industry, favorable government initiatives, and increasing disposable income levels contribute to market growth. Furthermore, the growing demand for sports nutrition supplements and performance-enhancing drugs in countries like China and India also fuels market expansion.

South America Steroids

According to Cognitive Market Research, the global Steroids market size was estimated at USD 3451.2 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 172.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031. In Latin America, the steroid market is driven by factors such as the increasing prevalence of chronic diseases like asthma and autoimmune disorders, rising healthcare expenditure, expanding access to healthcare services, growing awareness about treatment options, and advancements in pharmaceutical research and development. Additionally, the Region's aging population and changing lifestyles contribute to the demand for steroids—regulatory reforms aimed at improving healthcare infrastructure and affordability further fuel market growth in Latin America.

Middle East Steroids

According to Cognitive Market Research, the global Steroids market size was estimated at USD 3451.2 Million, out of which the Middle East and Africa held the major Market of around 2% of the global revenue with a market size of USD 69.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.8% from 2024 to 2031. Middle East and Africa, the steroids market is driven by factors such as increasing incidence of chronic diseases like asthma, rheumatoid arthritis, and dermatological conditions. Additionally, rising healthcare expenditure, improving access to healthcare services, and expanding awareness about treatment options contribute to market growth. Furthermore, the Region's growing population, urbanization, and adoption of Western lifestyles also play a role in driving demand for steroids and related pharmaceuticals.

Steroids Market Analysis

Steroids Type Segment Analysis

Corticosteroids, such as prednisone and dexamethasone, are synthetic drugs that mimic the actions of cortisol, a hormone naturally produced by the adrenal glands. They possess potent anti-inflammatory and immunosuppressive properties, making them indispensable for treating conditions like asthma, rheumatoid arthritis, and inflammatory skin disorders.

Hormones Steroids encompasses compounds that mimic the effects of naturally occurring hormones in the body. These steroids are often used in medical treatments to regulate hormone levels or in performance enhancement. Examples include testosterone, estrogen, and progesterone derivatives. Hormones steroids are crucial in treating conditions such as hormonal imbalances, certain cancers, and various inflammatory disorders. Their widespread applications make them a significant component of the overall steroids market.

• Corticosteroids
• Hormones Steroids

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Steroids Industry. Request a Free Sample PDF!

Steroids Form Segment Analysis

Skin patches, a form of transdermal delivery, offer advantages such as localized drug delivery, reduced systemic side effects, and improved patient compliance. They find extensive use in dermatological conditions like eczema, psoriasis, and allergic reactions. Additionally, hormone replacement therapy utilizing skin patches is gaining traction in endocrinology.

Inhalers, primarily delivering corticosteroids, play a crucial role in managing respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. Inhalation therapy offers rapid onset of action, targeted drug delivery to the airways, and minimized systemic exposure, enhancing efficacy while reducing side effects. The prevalence of respiratory diseases, particularly asthma, drives demand for inhaler-based steroids. Furthermore, advancements in inhaler technology, such as dry powder inhalers and metered-dose inhalers, improve drug delivery efficiency and patient convenience.

• Powder
• Granule
• Liquid

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Steroids Modes of Administration Segment Analysis

Oral steroids, taken by mouth in the form of tablets or capsules offer convenience and ease of administration. They are commonly prescribed for chronic conditions like asthma, autoimmune disorders, and inflammatory diseases. Examples include prednisone, dexamethasone, and methylprednisolone. Oral steroids are favored for their systemic effects and suitability for long-term therapy.

Injectable steroids are administered via intramuscular or intravenous routes, providing rapid onset of action and potentially higher bioavailability compared to oral forms. Injectable steroids are often preferred for acute exacerbations of inflammatory conditions or when immediate relief is required. Common injectable steroids include triamcinolone, betamethasone, and hydrocortisone.

• Skin Patches
• Inhalers
• Oral
• Injection
• Topical

Steroids Distribution Channels Segment Analysis

Hospital pharmacies serve as crucial distribution channels for steroids, particularly for acute conditions and severe illnesses requiring immediate medical intervention. These pharmacies cater to inpatients, outpatients, and healthcare facilities and offer a wide range of steroids, including corticosteroids for anti-inflammatory and immunosuppressive therapy and anabolic steroids for various medical indications. Hospital pharmacies prioritize patient safety, ensuring proper medication management and adherence to regulatory standards.

Retail pharmacies play a vital role in dispensing steroids for chronic conditions, long-term therapy, and self-medication purposes. These pharmacies cater to the general population, providing convenient access to steroids for conditions such as asthma, dermatitis, and hormone deficiencies. Retail pharmacies often offer over-the-counter steroids as well as prescription-based medications, and they provide personalized counseling and guidance to patients.

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion